Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Fresenius SE & Co. KGaA - SIC # 8081 -
Ticker
Exchange
SIC #
Website
Latest Ticker
FSNUY
Over the counter
8081
www.fresenius.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Fresenius SE & Co. KGaA
Chemed (CHE) Tops Q2 Earnings and Revenue Estimates
- Jul 28th, 2026 4:00 pm
Ensign Group (ENSG) Q2 Earnings and Revenues Top Estimates
- Jul 27th, 2026 5:15 am
Global Apheresis Market to Reach USD 4.41 Billion by 2031, Driven by Plasma-Based Therapies and Automated Technologies
- Jul 24th, 2026 8:46 am
Hikma and Fresenius best positioned from Trump's generic drug tariffs, says Citi
- Jul 23rd, 2026 6:17 am
Fresenius establishes venture fund of more than €200 million to drive healthcare innovation
- Jul 23rd, 2026 3:15 am
IV Equipment Market by Type, Application, End User - Global Forecast to 2031
- Jun 30th, 2026 5:32 am
Fresenius Medical Care dips after US proposes lower dialysis reimbursement rate
- Jun 25th, 2026 3:20 am
ISG Event to Explore How Enterprises Are Turning AI Investments Into Measurable Business Value
- Jun 18th, 2026 3:00 am
Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?
- Jun 15th, 2026 7:40 am
Fresenius (FMS) Q1 2026 Earnings Transcript
- Jun 1st, 2026 3:28 pm
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
- May 29th, 2026 7:40 am
Late-Stage Chronic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Novartis, Merck & Co, Pfizer, Sanofi, and Johnson & Johnson
- May 21st, 2026 7:21 am
How The Fresenius SE KGaA (XTRA:FRE) Investment Story Is Evolving With Mixed Analyst Targets
- Apr 23rd, 2026 1:07 pm
Quest Diagnostics Q1 Earnings Call Highlights
- Apr 21st, 2026 8:45 am
Fresenius Medical Care AG (FMS) Looks to Improve Profitability After Smashing Q4 Expectations
- Mar 13th, 2026 12:31 pm
Here's Why Fresenius (FMS) is a Strong Value Stock
- Mar 5th, 2026 7:40 am
Assessing Fresenius SE KGaA (XTRA:FRE) Valuation After Recent Earnings And Shareholder Returns
- Mar 1st, 2026 4:08 am
Pacira BioSciences, Inc. Q4 2025 Earnings Call Summary
- Feb 27th, 2026 6:30 am
Pacira BioSciences Q4 Earnings Call Highlights
- Feb 26th, 2026 11:12 pm
Fresenius SE & Co KGaA (FSNUY) Full Year 2025 Earnings Call Highlights: Strong Organic ...
- Feb 25th, 2026 12:03 pm
Scroll